Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease
- 14 February 2024
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 29 (6) , 489-496
Abstract
Background and Objective: Bronchoscopic transbronchial lung cryobiopsy (TBLC) is a guideline‐endorsed alternative to surgical lung biopsy for tissue diagnosis in unclassifiable interstitial lung disease (ILD). The reported incidence of post‐procedural bleeding has varied widely. We aimed to characterize the incidence, severity and risk factors for clinically significant bleeding following TBLC using an expert‐consensus airway bleeding scale, in addition to other complications and diagnostic yield.Methods: A retrospective cohort study of consecutive adult outpatients with unclassifiable ILD who underwent TBLC following multidisciplinary discussion at a single centre in the UK between July 2016 and December 2021. TBLC was performed under general anaesthesia with fluoroscopic guidance and a prophylactic endobronchial balloon.Results: One hundred twenty‐six patients underwent TBLC (68.3% male; mean age 62.7 years; FVC 86.2%; DLCO 54.5%). Significant bleeding requiring balloon blocker reinflation for >20 min, admission to ICU, packed red blood cell transfusion, bronchial artery embolization, resuscitation or procedural abandonment, occurred in 10 cases (7.9%). Significant bleeding was associated with traction bronchiectasis on HRCT (OR 7.1, CI 1.1–59.1, p = 0.042), a TBLC histological pattern of UIP (OR 4.0, CI 1.1–14, p = 0.046) and the presence of medium‐large vessels on histology (OR 37.3, CI 6.5–212, p < 0.001). BMI ≥30 (p = 0.017) and traction bronchiectasis on HRCT (p = 0.025) were significant multivariate predictors of longer total bleeding time (p = 0.017). Pneumothorax occurred in nine cases (7.1%) and the 30‐day mortality was 0%. Diagnostic yield was 80.6%.Conclusion: TBLC has an acceptable safety profile in experienced hands. Radiological traction bronchiectasis and obesity increase the risk of significant bleeding following TBLC.Keywords
This publication has 31 references indexed in Scilit:
- Risk factors of clinically significant complications in transbronchial lung cryobiopsy: A prospective multi-center studyRespiratory Medicine, 2022
- The safety profile of a protocolized transbronchial cryobiopsy program utilizing a 2.4 mm cryoprobe for interstitial lung diseaseRespiratory Medicine, 2022
- Perioperative Pulmonary Atelectasis: Part I. Biology and MechanismsAnesthesiology, 2021
- Cone Beam CT Guidance Improves Transbronchial Lung Cryobiopsy SafetyLung, 2021
- Standardized Definitions of Bleeding After Transbronchial Lung BiopsyChest, 2020
- Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung DiseasesChest, 2020
- Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyThe Lancet Respiratory Medicine, 2020
- Transbronchial Cryobiopsy in Interstitial Lung DiseaseJournal of Bronchology & Interventional Pulmonology, 2019
- Are Transbronchial Cryobiopsies Ready for Prime Time?Journal of Bronchology & Interventional Pulmonology, 2019
- Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung diseaseRespiratory Medicine, 2018